There is a nice case report about CABENUVA in pregnant woman in CID that was published in May 2024.
Lena van der Wekken-Pas, Fabian Weiss, Charlotte Simon-Zuber, Rena Sebisch, Carmen Wiese, Elisabeth van Leeuwen, David Burger, Angela Colbers, Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman Living With Human Immunodeficiency Virus, Clinical Infectious Diseases, 2024;, ciae242, https://doi.org/10.1093/cid/ciae242
Author does worry that RPV level may not be adequate if CABENUVA is given every 2 months and suggest, if have to continue CABENUVA, monthly dosing is preferred.
------------------------------
Chiu-Bin Hsiao, MD, FIDSA, AAHIVS
Allegheny General Hospital - Positive Health Clinic
Pittsburgh PA
------------------------------
Original Message:
Sent: 06-19-2024 18:02
From: Elizabeth Horvath
Subject: Cabenuva
I have a 40 y/o female currently on Odefsey, undetectable, who wants to switch to Cabenuva. She would be ideal candidate, however, the patient mentioned she is interested and seeking IVF for pregnancy. I counseled that we shouldn't switch ART and no studies known about pregnancy and Cabenuva, but she insists and says she will switch to a recommended regimen if/when pregnant and go back to Cabenuva after she gives birth. Any advice if moving forward at her insistence. She is not pregnant now
------------------------------
Elizabeth Horvath
Avenue360 Health & Wellness
Houston TX
------------------------------